Raltegravir - Latest Advances

Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.

Journal: Advanced emergency nursing journal

Published: September 08, 2025

Identification of a mouse-virulent recombinant type I/III Toxoplasma gondii strain in liver cytology of an immunosuppressed cat infected with FeLV-C subgroup.

Journal: Veterinary research communications

Published: July 14, 2025

Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada.

Journal: BMJ open

Published: July 05, 2025

Differential effects of antiretroviral HIV integrase inhibitors on vascular cell adhesion molecules.

Journal: Antiviral research

Published: June 26, 2025

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023.

Journal: Journal of virus eradication

Published: June 12, 2025

Association of HLA-B*53 With DRESS Syndrome in Patients Treated With Raltegravir: Two Case Reports and a Literature Review.

Journal: Basic & clinical pharmacology & toxicology

Published: June 03, 2025

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review.

Journal: International journal of molecular sciences

Published: May 26, 2025

Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical Samples.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: May 13, 2025

Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.

Journal: AIDS (London, England)

Published: May 01, 2025

Herbal formulations, Product Nkabinde and Gnidia sericocephala, exhibit potent in vitro activity against HIV-1 infection.

Journal: Frontiers in pharmacology

Published: April 25, 2025

HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations in ART-Naïve Individuals in South Korea from 2021 to 2024.

Journal: Viruses

Published: April 07, 2025

Quantification of dolutegravir, bictegravir, raltegravir and doravirine in human breastmilk with UPLC-MS/MS.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: April 03, 2025

Filters

Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.

Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.

Identification of a mouse-virulent recombinant type I/III Toxoplasma gondii strain in liver cytology of an immunosuppressed cat infected with FeLV-C subgroup.

Identification of a mouse-virulent recombinant type I/III Toxoplasma gondii strain in liver cytology of an immunosuppressed cat infected with FeLV-C subgroup.

Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada.

Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada.

Differential effects of antiretroviral HIV integrase inhibitors on vascular cell adhesion molecules.

Differential effects of antiretroviral HIV integrase inhibitors on vascular cell adhesion molecules.

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023.

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023.

Association of HLA-B*53 With DRESS Syndrome in Patients Treated With Raltegravir: Two Case Reports and a Literature Review.

Association of HLA-B*53 With DRESS Syndrome in Patients Treated With Raltegravir: Two Case Reports and a Literature Review.

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review.

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review.

Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical Samples.

Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical Samples.

Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.

Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.

Herbal formulations, Product Nkabinde and Gnidia sericocephala, exhibit potent in vitro activity against HIV-1 infection.

Herbal formulations, Product Nkabinde and Gnidia sericocephala, exhibit potent in vitro activity against HIV-1 infection.

HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations in ART-Naïve Individuals in South Korea from 2021 to 2024.

HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations in ART-Naïve Individuals in South Korea from 2021 to 2024.

Quantification of dolutegravir, bictegravir, raltegravir and doravirine in human breastmilk with UPLC-MS/MS.

Quantification of dolutegravir, bictegravir, raltegravir and doravirine in human breastmilk with UPLC-MS/MS.